China Approves Its Homegrown COVID-19 Vaccine For Widespread Use

Content Curator
A staff member checks a COVID-19 vaccine package in Beijing. China has approved Sinopharm

The state-owned Sinopharm says its vaccine has a 79% efficacy rate — surpassing the widely accepted standard of 50% efficacy.

(Image credit: Zhang Yuwei/Xinhua News Agency/Getty Images)